D
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Price:
18 760
KRW
4.8%
Market Cap:
₩848.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
|
KR |
|
Monroe Capital Corp
NASDAQ:MRCC
|
US |
|
B
|
Bright Outdoor Media Ltd
BSE:543831
|
IN |
|
Parshva Enterprises Ltd
BSE:542694
|
IN |
|
Indian Energy Exchange Ltd
NSE:IEX
|
IN |
|
Mowi ASA
OSE:MOWI
|
NO |
|
K
|
Kaulin Manufacturing Co Ltd
TWSE:1531
|
TW |
|
Genting Hong Kong Ltd
HKEX:678
|
HK |
Relative Value
The Relative Value of one Dongkook Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 18 760 KRW, Dongkook Pharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Dongkook Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Dongkook Pharmaceutical Co Ltd Competitors
Dongkook Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
D
|
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
|
832.8B KRW | 0.9 | 13.7 | 6.4 | 8.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
